CHAC - Chardan Healthcare Acquisition Corp.

NYSE American - Nasdaq Real Time Price. Currency in USD
10.55
-0.25 (-2.31%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close10.80
Open0.00
Bid10.35 x 800
Ask11.75 x 36200
Day's Range10.11 - 11.25
52 Week Range8.84 - 11.90
Volume25,844
Avg. Volume24,371
Market Cap92.313M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.

    Combined company renamed BiomX Inc. will trade on the NYSE American stock exchange under the symbol PHGE beginning October 29, 2019 NEW YORK and NESS ZIONA, Israel , Oct. 28, 2019 /PRNewswire/ -- Chardan ...

  • PR Newswire

    Chardan Healthcare Acquisition Corp. Shareholders Approve Definitive Merger Agreement with BiomX Ltd.

    NEW YORK and NESS ZIONA, Israel, Oct. 23, 2019 /PRNewswire/ -- Chardan Healthcare Acquisition Corp. (NYSE: CHAC, "CHAC"), a special purpose acquisition company sponsored by affiliates of Chardan Capital Markets LLC ("Chardan") announced today that its shareholders have voted to approve CHAC's previously announced business combination with BiomX Ltd. ("BiomX"), a microbiome company developing both natural and engineered phage therapies. More than 97% of the shares voted today at CHAC's special meeting of stockholders were voted in favor of the proposed transaction with BiomX.

  • ACCESSWIRE

    ACT NOW: Monteverde & Associates PC Continues Legal Inquiry Regarding the Merger

    NEW YORK, NY / ACCESSWIRE / October 19, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New ...

  • PR Newswire

    Chardan Healthcare Acquisition Corp. Announces Amendment to Merger Agreement with BiomX Ltd.

    NEW YORK and NESS ZIONA, Israel, Oct. 14, 2019 /PRNewswire/ -- Chardan Healthcare Acquisition Corp. (NYSE: CHAC, "CHAC"), a special purpose acquisition company ("SPAC") sponsored by affiliates of Chardan Capital Markets LLC ("Chardan") and BiomX Ltd. ("BiomX"), a microbiome company developing both natural and engineered phage therapies, announced that they entered into an amendment to their definitive agreement. Investors have committed or are expected to commit to an additional purchase of $5.0 million of CHAC shares. Cornix Advisors, LLC, an affiliate of Chardan, has entered into a securities purchase agreement with a current shareholder of CHAC to purchase $2.0 million of CHAC shares at $10.35 per share.

  • PR Newswire

    Lifshitz & Miller LLP Announces Investigation of Altria Group, Inc., Chardan Healthcare Acquisition Corporation, Premier, Inc., Restoration Robotics, Inc., Vivint Solar, Inc., Waitr Holdings Inc., Xilinx, Inc., and Zscaler, Inc.

    NEW YORK , Oct. 10, 2019 /PRNewswire/ -- Altria Group, Inc. (MO) Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that MO conducted insufficient ...

  • GlobeNewswire

    SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigations of Mergers

    WILMINGTON, Del., Oct. 03, 2019 -- Rigrodsky & Long, P.A. announces that it is investigating: Highlands Bankshares, Inc. (OTC Pink: HLND) regarding possible breaches of.

  • PR Newswire

    INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of the Following Merger

    Chardan Heathcare Acquisition Corp. (CHAC) related to its combination with BiomX Ltd. Pursuant to the terms of the Merger Agreement, BiomX's securityholders will receive an aggregate of 16,625,000 Chardan shares. As a result of the Proposed Transaction, Chardan's public stockholders will only own approximately 20% of Chardan's stock. Click here for more information: https://www.monteverdelaw.com/case/chardan-healthcare-acquisition-corp.  It is free and there is no cost or obligation to you. Restoration Robotics, Inc (HAIR) related to its combination with Venus Concept Ltd. Pursuant to the terms of the Merger Agreement, each share of Venus Concept will be converted into the right to receive 8.6506 shares of Restoration Robotics common stock.

  • PR Newswire

    Chardan Advises Health Sciences Acquisitions Corporation on Merger with Immunovant

    NEW YORK , Oct. 3, 2019 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm acted as M&A and Capital Markets Advisor for Health Sciences Acquisitions Corporation's (NASDAQ: ...

  • GlobeNewswire

    BiomX Hosting Key Opinion Leader Symposium on Novel Phage Product for Acne Prone Skin

    BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, today announced that it will host a Key Opinion Leader (KOL) meeting on a novel phage product for acne prone skin on Friday, September 13, 2019 in New York City. The event will feature a presentation by KOL Leon H. Kircik, MD., Associate Clinical Professor at Icahn School of Medicine at Mount Sinai, who will discuss the current product landscape and unmet need for improving acne prone skin. In addition, BiomX's management team will provide a review on the market opportunity, biological rationale of phage, and an update on the Company’s topically administered lead product candidate, BX001, intended to improve the appearance of acne-prone skin.

  • PR Newswire

    Chardan Healthcare Acquisition Corp. Announces Merger Agreement with BiomX Ltd.

    NEW YORK and NESS ZIONA, Israel, July 17, 2019 /PRNewswire/ -- Chardan Healthcare Acquisition Corp. (NYSE: CHAC, "CHAC"), a special purpose acquisition company ("SPAC") sponsored by affiliates of Chardan Capital Markets LLC ("Chardan"), announced today that it has entered into a definitive agreement for a business combination with BiomX Ltd. ("BiomX"), a microbiome company developing both natural and engineered phage therapies. Assuming no redemption of CHAC shareholders, the combined company will have an initial market capitalization of approximately $254 million. Upon closing of the transaction, it is expected that CHAC will be renamed BiomX and remain on the NYSE American Stock Exchange, listed under a new ticker symbol.

  • PR Newswire

    Chardan Serves as Lead Left Joint Book-Running Manager for Health Sciences Acquisitions Corporation

    NEW YORK , May 10, 2019 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm acted as lead left joint book runner in the initial public offering of Health Sciences Acquisitions ...